Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 15/20 | 0.55 |
| ▸ | NPY1R | P25929 | 9/20 | 0.55 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.55 |
| ▸ | NPY2R | P49146 | 5/20 | 0.55 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.45 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13188090 | 1.00 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2RKEAP1 | |
| SCHEMBL10075446 | 0.89 | NPY4R (0.54) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL13188643 | 0.88 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2RKEAP1 | |
| SCHEMBL13188046 | 0.88 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2RKEAP1 | |
| SCHEMBL2632395 | 0.86 | NPY4R (0.59) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL13188139 | 0.86 | NPY4R (0.59) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL10075166 | 0.86 | NPY4R (0.53) | NPY4RNPY1RNPY5RNPY2RKEAP1 | |
| SCHEMBL2623540 | 0.84 | NPY4R (0.54) | NPY4RNPY1RNPY5RNPY2RKEAP1 | |
| SCHEMBL2623546 | 0.84 | NPY4R (0.54) | NPY4RNPY1RNPY5RNPY2RKEAP1 | |
| SCHEMBL2632393 | 0.83 | NPY4R (0.52) | NPY4RNPY1RNPY5RNPY2RKEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120101257-A1 | PROCESSES FOR PREPARING AMINO-SUBSTITUTED GAMMA-LACTAMS | UNIVERSITE DE MONTREAL (CA) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120101257-A1 | PROCESSES FOR PREPARING AMINO-SUBSTITUTED GAMMA-LACTAMS | QPCT, GLUL, ASNS | NPY4R 2134/4885NPY1R 2063/4885NPY5R 1571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.